XML 13 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Equipment sales $ 24,619 $ 8,213 $ 29,727 $ 29,919
Chemicals 846 613 3,127 1,047
Consulting services and other 0 125 0 320
Total revenues 25,465 8,951 32,854 31,286
Operating expenses:        
Equipment sales cost of revenue, exclusive of depreciation and amortization 22,650 5,437 26,793 22,470
Chemicals cost of revenue, exclusive of depreciation and amortization 645 255 2,403 396
Consulting services and other cost of revenue, exclusive of depreciation and amortization 0 77 0 212
Payroll and benefits 2,033 3,956 4,215 7,759
Rent and occupancy 255 632 300 1,026
Legal and professional fees 1,219 1,982 2,254 4,965
General and administrative 809 1,346 2,072 2,092
Research and development, net (414) (345) (222) (143)
Depreciation and amortization 118 223 600 454
Total operating expenses 27,315 13,563 38,415 39,231
Operating loss (1,850) (4,612) (5,561) (7,945)
Other income (expense):        
Earnings from equity method investments 10,155 13,754 23,969 19,331
Royalties, related party 1,866 669 3,621 1,859
Interest expense (628) (1,573) (1,321) (3,537)
Revision in estimated royalty indemnity liability 500 0 3,400 0
Other 7 (279) 16 2,680
Total other income 11,900 12,571 29,685 20,333
Income before income tax expense 10,050 7,959 24,124 12,388
Income tax expense 3,642 99 9,028 152
Net income $ 6,408 $ 7,860 $ 15,096 $ 12,236
Earnings per common share (Note 1):        
Basic (in dollars per share) $ 0.29 $ 0.36 $ 0.68 $ 0.55
Diluted (in dollars per share) $ 0.29 $ 0.35 $ 0.68 $ 0.55
Weighted-average number of common shares outstanding:        
Basic (in shares) 21,866 21,875 21,961 21,895
Diluted (in shares) 21,880 22,187 21,981 22,204
Cash dividends declared per common share outstanding (in dollars per share) $ 0.25 $ 0 $ 0.25 $ 0